1. Home
  2. COE vs RCEL Comparison

COE vs RCEL Comparison

Compare COE & RCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

COE

51Talk Online Education Group

HOLD

Current Price

$21.65

Market Cap

140.9M

Sector

Real Estate

ML Signal

HOLD

Logo Avita Medical Inc.

RCEL

Avita Medical Inc.

HOLD

Current Price

$4.11

Market Cap

129.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
COE
RCEL
Founded
2011
N/A
Country
Singapore
United States
Employees
N/A
226
Industry
Other Consumer Services
Medical/Dental Instruments
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
140.9M
129.3M
IPO Year
2015
N/A

Fundamental Metrics

Financial Performance
Metric
COE
RCEL
Price
$21.65
$4.11
Analyst Decision
Buy
Analyst Count
0
5
Target Price
N/A
$7.88
AVG Volume (30 Days)
3.5K
270.2K
Earning Date
06-08-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$17.17
Revenue Next Year
N/A
$49.82
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$15.32
$3.22
52 Week High
$56.13
$7.12

Technical Indicators

Market Signals
Indicator
COE
RCEL
Relative Strength Index (RSI) 39.63 44.38
Support Level $21.50 $4.00
Resistance Level $23.50 $5.75
Average True Range (ATR) 1.17 0.30
MACD -0.56 -0.02
Stochastic Oscillator 25.00 17.78

Price Performance

Historical Comparison
COE
RCEL

About COE 51Talk Online Education Group

51 Talk Online Education Group is an online education platform in China, with core expertise in English education. The company's mission is to make quality education accessible and affordable. It's online and mobile education platforms enable students across China to take live interactive English lessons with overseas foreign teachers, on demand. The Group operates in seven principal geographical area: China, Hong Kong, Philippines, Singapore, Malaysia, Thailand and Saudi Arabia.

About RCEL Avita Medical Inc.

Avita is largely a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes, thus avoiding or reducing the need for skin grafts. It's approved for the treatment of adult and paediatric patients in the US and an expanded indication for soft-tissue reconstruction. It is currently used in most of the 140 US burn centers. Despite having product approval in Australia, Canada, and China, Avita is not actively marketing in those territories and focussing instead on the US region, although international sales, particularly in Japan, are growing. Avita is domiciled, and has its primary listing, in the US.

Share on Social Networks: